Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Einarsdóttir, A B
MetadataShow full item record
CitationDiabetologia 2011, 54(10):2525-32
AbstractAIMS/HYPOTHESIS: The aim of this study was to reduce the frequency of diabetic eye-screening visits, while maintaining safety, by using information technology and individualised risk assessment to determine screening intervals. METHODS: A mathematical algorithm was created based on epidemiological data on risk factors for diabetic retinopathy. Through a website, www.risk.is , the algorithm receives clinical data, including type and duration of diabetes, HbA(1c) or mean blood glucose, blood pressure and the presence and grade of retinopathy. These data are used to calculate risk for sight-threatening retinopathy for each individual's worse eye over time. A risk margin is defined and the algorithm recommends the screening interval for each patient with standardised risk of developing sight-threatening retinopathy (STR) within the screening interval. We set the risk margin so that the same number of patients develop STR within the screening interval with either fixed annual screening or our individualised screening system. The database for diabetic retinopathy at the Department of Ophthalmology, Aarhus University Hospital, Denmark, was used to empirically test the efficacy of the algorithm. Clinical data exist for 5,199 patients for 20 years and this allows testing of the algorithm in a prospective manner. RESULTS: In the Danish diabetes database, the algorithm recommends screening intervals ranging from 6 to 60 months with a mean of 29 months. This is 59% fewer visits than with fixed annual screening. This amounts to 41 annual visits per 100 patients. CONCLUSION: Information technology based on epidemiological data may facilitate individualised determination of screening intervals for diabetic eye disease. Empirical testing suggests that this approach may be less expensive than conventional annual screening, while not compromising safety. The algorithm determines individual risk and the screening interval is individually determined based on each person's risk profile. The algorithm has potential to save on healthcare resources and patients' working hours by reducing the number of screening visits for an ever increasing number of diabetic patients in the world.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to Diabetologia
- Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs.
- Authors: Lund SH, Aspelund T, Kirby P, Russell G, Einarsson S, Palsson O, Stefánsson E
- Issue date: 2016 May
- Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice.
- Authors: Estil S, Steinarsson AÞ, Einarsson S, Aspelund T, Stefánsson E
- Issue date: 2020 Jun
- External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus.
- Authors: Soto-Pedre E, Pinies JA, Hernaez-Ortega MC
- Issue date: 2015 May-Jun
- Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathy.
- Authors: van der Heijden AA, Walraven I, van 't Riet E, Aspelund T, Lund SH, Elders P, Polak BC, Moll AC, Keunen JE, Dekker JM, Nijpels G
- Issue date: 2014 Jul
- Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.
- Authors: Ochs A, McGurnaghan S, Black MW, Leese GP, Philip S, Sattar N, Styles C, Wild SH, McKeigue PM, Colhoun HM, Scottish Diabetes Research Network Epidemiology Group and the Diabetic Retinopathy Screening Collaborative.
- Issue date: 2019 Oct